Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

514 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cannabidiol for at risk for psychosis youth: A randomized controlled trial.
Amminger GP, Lin A, Kerr M, Weller A, Spark J, Pugh C, O'Callaghan S, Berger M, Clark SR, Scott JG, Baker A, McGregor I, Cotter D, Sarnyai Z, Thompson A, Yung AR, O'Donoghue B, Killackey E, Mihalopoulos C, Yuen HP, Nelson B, McGorry PD. Amminger GP, et al. Among authors: weller a. Early Interv Psychiatry. 2022 Apr;16(4):419-432. doi: 10.1111/eip.13182. Epub 2021 Jun 30. Early Interv Psychiatry. 2022. PMID: 34190422 Clinical Trial.
Can antipsychotic dose reduction lead to better functional recovery in first-episode psychosis? A randomized controlled-trial of antipsychotic dose reduction. The reduce trial: Study protocol.
Weller A, Gleeson J, Alvarez-Jimenez M, McGorry P, Nelson B, Allott K, Bendall S, Bartholomeusz C, Koval P, Harrigan S, O'Donoghue B, Fornito A, Pantelis C, Paul Amminger G, Ratheesh A, Polari A, Wood SJ, van der El K, Ellinghaus C, Gates J, O'Connell J, Mueller M, Wunderink L, Killackey E. Weller A, et al. Early Interv Psychiatry. 2019 Dec;13(6):1345-1356. doi: 10.1111/eip.12769. Epub 2018 Nov 29. Early Interv Psychiatry. 2019. PMID: 30488637
The addition of fluoxetine to cognitive behavioural therapy for youth depression (YoDA-C): a randomised, double-blind, placebo-controlled, multicentre clinical trial.
Davey CG, Chanen AM, Hetrick SE, Cotton SM, Ratheesh A, Amminger GP, Koutsogiannis J, Phelan M, Mullen E, Harrison BJ, Rice S, Parker AG, Dean OM, Weller A, Kerr M, Quinn AL, Catania L, Kazantzis N, McGorry PD, Berk M. Davey CG, et al. Among authors: weller a. Lancet Psychiatry. 2019 Sep;6(9):735-744. doi: 10.1016/S2215-0366(19)30215-9. Epub 2019 Jul 29. Lancet Psychiatry. 2019. PMID: 31371212 Clinical Trial.
Youth Depression Alleviation with Anti-inflammatory Agents (YoDA-A): a randomised clinical trial of rosuvastatin and aspirin.
Berk M, Mohebbi M, Dean OM, Cotton SM, Chanen AM, Dodd S, Ratheesh A, Amminger GP, Phelan M, Weller A, Mackinnon A, Giorlando F, Baird S, Incerti L, Brodie RE, Ferguson NO, Rice S, Schäfer MR, Mullen E, Hetrick S, Kerr M, Harrigan SM, Quinn AL, Mazza C, McGorry P, Davey CG. Berk M, et al. Among authors: weller a. BMC Med. 2020 Jan 17;18(1):16. doi: 10.1186/s12916-019-1475-6. BMC Med. 2020. PMID: 31948461 Free PMC article. Clinical Trial.
Discontinuation of antipsychotic medication-time to rethink trial design.
Speyer H, Begemann M, Albert N, Weller A, Nordentoft M, Veling W, Sommer IE, Allott K, Killackey E. Speyer H, et al. Among authors: weller a. Lancet Psychiatry. 2020 Oct;7(10):841-842. doi: 10.1016/S2215-0366(20)30340-0. Lancet Psychiatry. 2020. PMID: 32949515 No abstract available.
The Addition of Fish Oil to Cognitive Behavioral Case Management for Youth Depression: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical Trial.
Amminger GP, Rice S, Davey CG, Quinn AL, Hermens DF, Zmicerevska N, Nichles A, Hickie I, Incerti L, Weller A, Joseph S, Hilton Z, Pugh C, Rayner M, Reid N, Ratheesh A, Yung AR, Yuen HP, Mackinnon A, Hetrick S, Parker A, Street R, Berger M, Berk M, McGorry PD, Lin A. Amminger GP, et al. Among authors: weller a. Biol Psychiatry. 2024 Mar 1;95(5):426-433. doi: 10.1016/j.biopsych.2023.06.015. Epub 2023 Jun 22. Biol Psychiatry. 2024. PMID: 37355004 Clinical Trial.
The Study of Ketamine for Youth Depression (SKY-D): study protocol for a randomised controlled trial of low-dose ketamine for young people with major depressive disorder.
Schwartz OS, Amminger P, Baune BT, Bedi G, Berk M, Cotton SM, Daglas-Georgiou R, Glozier N, Harrison B, Hermens DF, Jennings E, Lagopoulos J, Loo C, Mallawaarachchi S, Martin D, Phelan B, Read N, Rodgers A, Schmaal L, Somogyi AA, Thurston L, Weller A, Davey CG. Schwartz OS, et al. Among authors: weller a. Trials. 2023 Oct 24;24(1):686. doi: 10.1186/s13063-023-07631-3. Trials. 2023. PMID: 37875938 Free PMC article.
Unraveling the molecular basis of cannabidiolic acid methyl Ester's anti-depressive effects in a rat model of treatment-resistant depression.
Hen-Shoval D, Indig-Naimer T, Moshe L, Kogan NM, Zaidan H, Gaisler-Salomon I, Okun E, Mechoulam R, Shoval G, Zalsman G, Weller A. Hen-Shoval D, et al. Among authors: weller a. J Psychiatr Res. 2024 Apr 24;175:50-59. doi: 10.1016/j.jpsychires.2024.04.033. Online ahead of print. J Psychiatr Res. 2024. PMID: 38704981
A Gold(I)-Acetylene Complex Synthesised using Single-Crystal Reactivity.
Johnson CL, Storm DJ, Sajjad MA, Gyton MR, Duckett SB, Macgregor SA, Weller AS, Navarro M, Campos J. Johnson CL, et al. Among authors: weller as. Angew Chem Int Ed Engl. 2024 May 3:e202404264. doi: 10.1002/anie.202404264. Online ahead of print. Angew Chem Int Ed Engl. 2024. PMID: 38699962
514 results